ESTABLISHMENT OF A RABBIT SHORT-TERM DRY EYE MODEL

被引:49
作者
FUJIHARA, T
NAGANO, T
NAKAMURA, M
SHIRASAWA, E
机构
[1] Santen Pharmaceutical Co., Ltd., Ophthalmic Research Laboratories, Osaka
关键词
D O I
10.1089/jop.1995.11.503
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The dry eye syndrome is a chronic disease which can become a serious threat to useful vision. However, there is only a limited understanding regarding effective treatment or prevention of this disease. Establishing an effective mode of treatment requires the use of a satisfactory animal dry eye model. Ideally, such a model should rapidly determine the effectiveness of agents that inhibit the damaging effects of this syndrome. This paper presents a short-term dry eye model using rabbits, which combines mechanical prevention of blinking and methylene blue staining. This model is not intended to be a precise representation of the dry eye syndrome, since this disorder has recently become recognized to involve a primary pathological process of the corneal and conjunctival epithelium. However, by using this model, clinical signs of dry eye can be observed after a few hours in the form of acute desiccation. Corneal damage can easily be evaluated both qualitatively by methylene blue staining scores, and quantitatively by chronic assay. Visually observed corneal epithelial thinning was confirmed by scanning electron microscopy (SEM) to be due to loss of epithelial integrity. Using a 3 % chondroitin sulfate solution, an already proven effective agent for dry eye, this model effectively demonstrated an 80 % inhibition in the development of methylene blue positive lesion after a period of only 2 hours. This short term dry eye model is valuable in primarily screening the efficacy of potential therapeutic agents in the prevention and treatment of dry eye.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 14 条
[1]  
Lemp M.A., Basic principle and classification of dry eye disorder, The dry eye
[2]  
a comprehensive guide, pp. 101-131, (1992)
[3]  
Driot J., Bonnet C., Beneficial effects of a retinoic acid analog, CBS-211 A, on an experimental model of keratoconjuntivitis sicca, Invest. Ophthalmol. Vis. Sci., 33, pp. 190-195, (1992)
[4]  
Jabs D.A., Enger C., Prendergast R.A., Murine models of Sjogren's syndrome, Invest. Ophthalmol. Vis. Sci., 32, pp. 371-380, (1991)
[5]  
Gilbard J.P., Rossi S.R., Gray K.L., A new rabbit model for keratoconjunctivitis sicca, Invest. Ophthalmol. Vis. Sci., 28, pp. 225-228, (1987)
[6]  
Gilbard J.P., Rossi S.R., Gray K.L., Hanninen L.A., Kenyon K.R., Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca, Invest. Ophthalmol. Vis. Sci., 29, pp. 374-378, (1988)
[7]  
Francis J., Maudgal P.C., Victoria-troncoco V., Experimental keratitis sicca, Ophthalmic Res., 8, pp. 414-424, (1976)
[8]  
Beitch I., The induction of keratinization in the corneal epithelium. A comparison of the “dry” and vitamin A-deficient eyes, Invest. Ophthalmol., 9, pp. 827-842, (1970)
[9]  
Kessler H.S., Cubberly M., Manski W.M., Eye changes in autoimmune NZB and NZW x NZW mice. Comparison with Sjogren's syndrome, Arch Ophthal., 85, pp. 211-219, (1971)
[10]  
Levenson J.E., The effect of short-term drying on the surface ultrastructure of the rabbit cornea: a scanning electron microscopic study, Annual. Ophthalmol, pp. 865-877, (1973)